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ABSTRACT 
Objective: To develop a rapid, sensitive, accurate, precise, linear and rugged Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) 
method and validate as per ICH guidelines for the quantitative estimation of Eplerenone in tablets.  
Methods: The optimized method uses a reverse phase column, Waters Symmetry C18 (250 X 4.6 mm; 5μ), a mobile phase of triethylammonium 
phosphate buffer (pH 2.3):acetonitrile in the proportion of 40:60 v/v, flow rate of 1.0 ml/min and a detection wavelength of 240 nm using a UV detector.  
Results: The developed method resulted in Eplerenone eluting at 3.63 min. Eplerenone exhibited linearity in the range 15-45μg/ml. The precision 
is exemplified by relative standard deviation of 0.34%. Percentage Mean recovery was found to be in the range of 98- 102, during accuracy studies. 
The limit of detection (LOD) and limit of quantitiation (LOQ) was found to be 39.16μg/ml and 118.66μg/ml respectively. 
Conclusion: A sensitive, rapid, accurate, precise, linear and rugged RP-HPLC method was developed and validated for the quantitative estimation of 
Eplerenone in tablets as per ICH guidelines and hence it can be used for routine analysis in various pharmaceutical industries.  
Keywords: RP-HPLC, Eplerenone, Method development, Validation. 
 
INTRODUCTION 
Eplerenone (fig. 1) is pregen-4-ene-7, 21-dicarboxylic acid, 9, 11-
epoxy-17-hydroxy-3-oxo, γ-lactone, methyl ester (7α, 11α, 17α) [1, 3]. 
It has a molecular formula of C24H30O6
cardiovascular
 and a molecular mass of 
414.49. Eplerenone is the first highly selective aldosterone receptor 
antagonist (SARA) to effectively block aldosterone at receptor sites 
in body tissues, aldosterone being a component of rennin-
angiotensin-aldosterone system [1-6]. Eplerenone is used for 
treatment of hypertension and heart failure [1-6]. Eplerenone is 
specifically indicated for the reduction of risk of  
death in people with heart failure and left ventricular dysfunction 
within 3–14 d of an acute myocardial infarction, in combination with 
standard therapies and as treatment against hypertension. It 
appears equivalent to spironolactone but is much more expensive 
[7]. It is marketed by Pfizer under the trade name Inspra.  
 
 
Fig. 1: Structure of Eplerenone 
 
Eplerenone is a potassium-sparing diuretic, meaning that it helps the 
body get rid of water but still keep potassium. Few analytical 
methods have been reported for the determination of Eplerenone in 
biological fluids by LCMS [8-9], in bulk and formulations by UV 
Spectroscopy [10-11], TLC/Densitometry [1] and RP-HPLC [3, 12]. 
Literature reveals use of potassium dihydrogen orthophosphate as 
buffer (pH 3.2) and ammonium acetate buffer (pH 7.0) along with 
organic modifier as mobile phase for assay methods in formulations 
using RP-HPLC. As there is no literature reported on using triethyl 
ammonium phosphate as aqueous media along with organic 
modifier, we here report a new and a rapid RP-HPLC validated 
method for the quantitative estimation of Eplerenone in tablets 
using triethyl ammonium phosphate buffer (pH 2.3) along with 
acetonitrile as mobile phase. 
MATERIALS AND METHODS 
Chemicals and reagents 
Analytically pure sample of Eplerenone with purities greater than 
95% was obtained as the gift sample from Chandra labs, Hyderabad, 
India and tablet formulation [PLANEP] was procured from Apollo 
Pharmacy, Hyderabad, India with labelled amount 25 mg of 
Eplerenone. Acetonitrile (HPLC grade), water (HPLC grade), 
Triethylamine (AR Grade) and ortho phosphoric acid (AR Grade) 
were obtained from SD Fine chemicals (Hyderabad, India), 0.45 and 
0.22μm Nylon membrane filters were obtained from Spincotech 
Private Limited, Hyderabad, India.  
Instrument 
HPLC analysis was performed on Shimadzu LC-20AD Prominence 
Liquid Chromatograph comprising a LC-20AD pump, Shimadzu SPD-
20A Prominence UV-VISIBLE detector and a reverse phase C18 
column, Waters Symmetry (250 X 4.6 mm; 5μ). A manually operating 
Rheodyne injector with 20 μL sample loop was equipped with the 
HPLC system. The HPLC system was controlled with “Lab solutions 
lite” software. A double beam UV-visible spectrophotometer 
(Shimadzu, model UV-1800) having two matched quartz cells with 1 
cm light path and loaded with UV probe software (version 2.41) was 
used for recording of spectra and measuring absorbance. An 
electronic analytical weighing balance (0.1 mg sensitivity, Shimadzu 
AY 220), digital pH meter (DELUX model 101), a sonicator (sonica, 
model 2200 MH).  
Method 
Selection of wavelength 
Suitable wavelength for the HPLC analysis was determined by 
recording UV spectrum in the range of 200-400 nm for Eplerenone. 
Suitable wavelength selected was 240 nm (fig. 2). 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491              Vol 7, Issue 11, 2015 
Innovare 
Academic Sciences 
Ashok et al. 




Fig. 2: UV spectrum of eplerenone 
 
Chromatographic conditions 
The developed method uses a reverse phase C18 column, Waters 
Symmetry C18 (250 X 4.6 mm; 5μ), mobile phase of 
triethylammonium phosphate buffer (pH 2.3): acetonitrile in the 
proportion of 40:60 v/v. The mobile phase was set at a flow rate of 
1.0 ml/min and the volume injected was 20μl for every injection. 
The detection wavelength was set at 240 nm.  
Buffer preparation 
The buffer solution was prepared by adding 5 ml of triethylamine to 
1000 ml of HPLC grade water and later pH was adjusted to 2.3 using 
30% v/v of ortho phosphoric acid in water. The buffer was then 
filtered through 0.45 μm nylon membrane filter.  
Mobile phase preparation 
The mobile phase was prepared by mixing buffer and acetonitrile in 
the ratio of 40:60 v/v and later it was sonicated for 10 min for the 
removal of air bubbles.  
Preparation of stock and working standard solution 
10 mg of Eplerenone was accurately weighed and taken in 100 ml 
clean and dry volumetric flask containing 50 ml of diluent (same as 
mobile phase) and then sonicated for 2 min to dissolve. Later the 
solution was made up to the mark using the mobile phase. This is 
considered as the stock standard solution (100µg/ml). From the stock 
solution, 3 ml was pipetted out and to 10 ml using the mobile phase to 
get a concentration of 30µg/ml, treated as 100% target concentration.  
Preparation of stock and working sample solution 
Not less than 20 tablets were weighed and taken into a mortar, crushed 
and then uniformly mixed. Test stock solution of Eplerenone (500μg/ml) 
was prepared by transferring weight equivalent to 25 mg of Eplerenone 
to 40 ml of a mobile phase which is sonicated for 4 min and later made 
up to 50 ml with the mobile phase. This solution was filtered using 
0.22micron syringe filter. From the above stock solution 0.6 ml was 
pipetted out and made up to 10 ml to get working sample solution 
equivalent to a concentration of 30µg/ml for Eplerenone, concentration 
equal to 100% target concentration. 
RESULTS AND DISCUSSION 
Method development 
A Reverse phase HPLC method was developed keeping in mind the 
system suitability parameters i.e. tailing factor (T), number of theoretical 
plates (N), runtime and the cost effectiveness. The optimized method 
developed resulted in the elution of Eplerenone at 3.63 min. Fig. 3 and 4 
represent chromatograms of blank solution and the standard solution 
(30µg/ml) respectively. The total run time is 6 min. System suitability 
tests are an integral part of method development and are used to ensure 
adequate performance of the chromatographic system. Retention time 
(RT), number of theoretical plates (N) and peak Tailing factor (T) were 
evaluated for injection of the standard at the working concentration. The 
results are given in table 1. 
In order to test the applicability of the developed method to a 
commercial formulation, PLANEP was chromatographed at working 
concentration (30µg/ml) and it is shown in fig. 5. The sample peak 
was identified by comparing the retention time with the standard 
drug fig. 4. System suitability parameters were within the 
acceptance limits, ideal for the chromatographed sample. Integration 
of separated peak area was done and drug concentration was 
determined by using the peak area concentration relationship 
obtained in the standardization step. The protocol affords 
reproducible assay of the drug in the sample ranging between 98 




Fig. 3: Typical chromatogram of blank solution 
 
Table 1: System suitabilitystudies results 
Parameters Eplerenone 
Retention time (min) 3.63 
Number Of Theoretical plates (N) 5954 
Tailing factor (T) 1.82 
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Fig. 4: Typical chromatogram of the standard solution 
 
 
Fig. 5: Typical chromatogram for the tablet formulation. 
 
Method validation 
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical application. 
RP-HPLC method developed was validated according to International 
Conference on Harmonization (ICH) guidelines [13] for validation of 
analytical procedures. The method was validated for the parameters 
like system suitability, specificity, linearity, accuracy, precision, and 
ruggedness, limit of detection (LOD) and limit of quantitiation (LOQ). 
Specificity 
Fig. 3-5 for blank, standard drug solution and sample chromatogram 
reveal that the peaks obtained in the standard solution and the sample 
solution at working concentrations are only because of the drug as 
blank has no peak at the retention time of Eplerenone. Accordingly it 
can be concluded that, the method developed is said to be specific. 
Precision 
System precision 
Six replicate injections of the standard solution at the working 
concentration showed % RSD (Relative Standard Deviation) less 
than 2 concerning peak area for the drug, which indicates the 
acceptable reproducibility and thereby the precision of the system. 
System precision results are tabulated in table 2. 
Method precision 
Method precision was determined by performing assay of sample under 
the tests of repeatability (Intraday precision) at working concentration.  
Repeatability (Intraday precision) 
Six consecutive injections of the sample from the same 
homogeneous mixture at working concentration showed % RSD less 
than 2 concerning % assay for the drug which indicate that the 
method developed is method precise by the test of repeatability and 
hence can be understood that the method gives consistently 
reproducible results (table 3). 
Linearity 
Standard solutions of Eplerenone at different concentrations level 
(50%, 75%, 100%, 125% and 150%) were prepared. Calibration 
curve was constructed by plotting the concentration level of drug 
versus the corresponding peak area. The results show an excellent 
correlation between peak area and concentration level of drug 
within the concentration range (15-45µg/ml) for the drug and the 
results are given in table 4 and fig. 6. The correlation coefficient of 
Eplerenone is 0.998 and hence the method is said to be linear. 
Accuracy 
Accuracy was determined by means of recovery experiments, by the 
determination of % mean recovery of sample at three different 
levels (50-150%). At each level, three determinations were 
performed. Percent mean recovery was calculated as shown in table 
5. The accepted limits of recovery are 98%-102% and all observed 
data are within the required range which indicates good recovery 
values and hence the accuracy of the method developed. 
Sensitivity 
The sensitivity of measurement of Eplerenone by use of the 
proposed method was estimated in terms of the limit of quantitation 
(LOQ) and the limit of detection (LOD). LOQ and LOD were 
calculated by the use of the equations LOD = 3.3σ/S and LOQ = 
10σ/S where σ is the standard deviation of response of calibration 
plot and S is the slope of the corresponding calibration plot. The 
limit of detection (LOD) and limit of quantitiation (LOQ) was found 
to be 39.16μg/ml and 118.66μg/ml respectively. 
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Table 2: System precision results of Eplerenone 
Injection no. (n) RT Peak Area 
1 3.631 1728619 
2 3.642 1712266 
3 3.634 1724394 
4 3.634 1722646 
5 3.648 1720596 
Average 3.637 1721704 
Standard Deviation 0.007 6046.5 
%RSD 0.192 0.351 
 
Table 3: Intraday precision results of Eplerenone 
n RT Peak area %Assay 
1 3.632 1746464 101.43 
2 3.624 1751581 101.73 
3 3.628 1743313 101.25 
4 3.632 1755407 101.95 
5 3.631 1752102 101.76 
6 3.628 1739400 101.02 
Average 3.628 1755378 101.52 
Standard Deviation 0.0028 12136.2 0.35 
%RSD 0.077 0.691 0.344 
 
Table 4: Calibration data for Eplerenone 
% Level Concentration (µg/ml) Peak area 
50 15 838943 
75 22.5 1221643 
100 30 1631265 
125 37.5 2059254 
150 45 2525331 
Regression coefficient  0.998 
Regression equation  y=56138.5x-28868 
 
 
Fig. 6: Linearity graph of Eplerenone 
 
Table 5: Results of Accuracy studies for Eplerenone 























Ashok et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 11, 360-364 
 
364 
Table 6: Ruggedness results of Eplerenone 
n RT Peak area %Assay 
1 3.627 1740565 101.095 
2 3.629 1736765 100.875 
3 3.637 1745625 101.389 
4 3.641 1735499 100.801 
5 3.641 1740967 101.119 
6 3.641 1750437 101.669 
Average 3.636 1741643 101.15 
Standard deviation 0.005 5104.79 0.322 
%RSD 0.161 0.293 0.318 
 
Ruggedness 
Ruggedness was evaluated by performing assay of the formulations 
by different analyst by injecting six consecutive injections of the 
sample at the working concentration from the same homogeneous 
mixture of tablets. This study showed % RSD less than 2 concerning 
% assay for both the drugs which indicate that the method 
developed is rugged and hence can be understood that the method 
gives reproducible results irrespective of analyst (table 6). 
CONCLUSION 
A reverse phase HPLC isocratic method developed has been validated as 
per ICH guidelines in terms of specificity, accuracy, precision, linearity, 
and ruggedness, limit of detection and limit of quantitation, for the 
quantitative estimation of Eplerenone in tablets. The precision is 
exemplified by relative standard deviation of 0.34%. A good linear 
relationship was observed for the drug between concentration ranges of 
15 and 45µg/ml. Accuracy studies revealed that mean recoveries were 
between 98 and 102%, an indicative of accurate method. The limit of 
detection (LOD) and limit of quantitiation (LOQ) was found to be 
39.16μg/ml and 118.66μg/ml respectively. Accordingly it can be 
concluded that the developed reverse phase isocratic HPLC method is 
sensitive, accurate, precise, linear and rugged and therefore the method 
can be used for the routine analysis of Eplerenone in tablets. 
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